The risk of hepatocellular carcinoma is decreasing after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B. (Q40157059)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28622419%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

title

The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28622419%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

1 reference

hepatocellular carcinoma

1 reference

1 reference

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28622419%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Thomas Berg

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28622419%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Rafael Esteban

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28622419%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

4

Maria Buti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28622419%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

15

Bettina E Hansen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28622419%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

author name string

George V Papatheodoridis

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28622419%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Ramazan Idilman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28622419%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

George N Dalekos

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28622419%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Heng Chi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28622419%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Florian van Boemmel

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28622419%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Jose Luis Calleja

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28622419%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Vana Sypsa

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28622419%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

John Goulis

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28622419%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Spilios Manolakopoulos

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28622419%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Onur Keskın

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28622419%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Nikolaos Gatselis

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28622419%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Maria Lehretz

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28622419%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Juan de la Revilla

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28622419%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Savvoula Savvidou

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28622419%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Anastasia Kourikou

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28622419%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Ioannis Vlachogiannakos

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28622419%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Kostantinos Galanis

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28622419%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Cihan Yurdaydin

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28622419%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Massimo Colombo

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28622419%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Harry L A Janssen

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28622419%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Pietro Lampertico

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28622419%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Spyros Siakavellas

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28622419%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

language of work or name

English

0 references

publication date

11 October 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28622419%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28622419%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

volume

66

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28622419%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

page(s)

1444-1453

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28622419%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28622419%20AND%20SRC:MED&resulttype=core&format=json

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

23 March 2020

cites work

1 reference

Therapeutic strategies in the management of patients with chronic hepatitis B virus infection.

21 January 2018

1 reference

AASLD guidelines for treatment of chronic hepatitis B.

21 January 2018

1 reference

Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review.

21 January 2018

1 reference

Risk of hepatocellular carcinoma in chronic hepatitis B: assessment and modification with current antiviral therapy.

21 January 2018

1 reference

Hepatocellular carcinoma in chronic hepatitis B patients under antiviral therapy.

21 January 2018

1 reference

Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection

21 January 2018

1 reference

Accuracy of risk scores for patients with chronic hepatitis B receiving entecavir treatment

21 January 2018

1 reference

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

21 January 2018

1 reference

Clinical scoring system to predict hepatocellular carcinoma in chronic hepatitis B carriers.

21 January 2018

1 reference

Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score.

21 January 2018

1 reference

PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy.

21 January 2018

1 reference

Risk stratification and therapeutic decision making in acute coronary syndromes

21 January 2018

1 reference

Impact of long-term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B.

21 January 2018

1 reference

Effect of nucleos(t)ide analogue therapy on hepatocarcinogenesis in chronic hepatitis B patients: a propensity score analysis

21 January 2018

1 reference

Clinical outcomes after interruption of entecavir therapy in HBeAg-negative chronic hepatitis B patients with compensated cirrhosis

21 January 2018

1 reference

Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients.

21 January 2018

1 reference

Mechanisms of HBV-induced hepatocellular carcinoma.

21 January 2018

1 reference

Optimal management of hepatitis B virus infection - EASL Special Conference

21 January 2018

1 reference

Management of hepatocellular carcinoma

21 January 2018

1 reference

Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study

21 January 2018

1 reference

21 January 2018

1 reference

Transient elastography in chronic viral hepatitis: a critical appraisal.

21 January 2018

1 reference

Non-invasive assessment of liver fibrosis: are we ready?

21 January 2018

1 reference

Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy

21 January 2018

1 reference

Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B

21 January 2018

1 reference

Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Gr

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/HEP.29320

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28622419%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

1 reference